Details of the Drug Reposition

General Information of This Drug (ID: DM9NJXX)

Drug Name
Pneumostem   DM9NJXX

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Respiratory distress syndrome DISPAKGA CB00 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Bronchopulmonary dysplasia DISO0BY5 KB29.0 Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01897987) Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM Phase-II Clinical Trial. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)